Advertisement

The Effects of Streptokinase and Tissue Plasminogen Activator on Left Ventricular Function

  • Harvey D. White
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 281)

Abstract

One of the major questions remaining in thrombolysis is which drug we should be using. In terms of “head to head” comparisons there are few data. Streptokinase and tissue plasminogen activator have been compared in terms of patency and tissue plasminogen activator has been shown to be superior (1, 2). However, patency cannot be directly extrapolated to patient benefit and direct comparisons of the effects of these drugs on left ventricular function and mortality are required. Left ventricular function can be considered as a surrogate for mortality but in addition the assessment of left ventricular function also evaluates the capacity of a patient to exercise, and relates to quality of life. In this study the effects of streptokinase and tissue plasminogen activator on left ventricular function were compared.

Keywords

Left Ventricular Function Tissue Plasminogen Activator Intravenous Streptokinase Left Main Disease Intracoronary Streptokinase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. H. Chesebro, G. Knatterud, R. Roberts et al, Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous plasminogen activator and intravenous streptokinase, Circulation,76:142–54 (1987).PubMedCrossRefGoogle Scholar
  2. 2.
    M. Verstraete, R. Bernard, M. Bory et al, Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction, Lancet, I:842–7 (1985).CrossRefGoogle Scholar
  3. 3.
    H. D. White, R. M. Norris, M. A. Brown, P. W. T. Brandt, R. M. L. Whitlock, and C. J. Wild, Left ventricular end-systolic volume is the major determinant of survival after recovery from myocardial infarction, Circulation, 76:44–51 (1987).PubMedCrossRefGoogle Scholar
  4. 4.
    R. M. Norris and H. D. White, Therapeutic trials in coronary thrombolysis should measure left ventricular function as the primary end-point of treatment, Lancet,I:1046 (1988).Google Scholar
  5. 5.
    H. D. White, R. M. Norris, M. A. Brown et al, Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction, N. Engl. J. Med., 317:850–5 (1987).PubMedCrossRefGoogle Scholar
  6. 6.
    P. W. Serruys, M. L. Simoons, H. Suryapranata et al, Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction, J. Am. Coll. Cardiol.,7:729–42 (1986).PubMedCrossRefGoogle Scholar
  7. 7.
    F. Van der Werf, and A. E. R. Arnold for the European cooperative study group for recombinant tissue type plasminogen activator (rt-PA), Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction, Br. Med. J., 297:1374–9 (1988).Google Scholar
  8. 8.
    M. L. Simoons, P. W. Serruys, M. van den Brand et al., Improved survival after early thrombolysis in acute myocardial infarction, Lancet, II:578–81 (1985).CrossRefGoogle Scholar
  9. 9.
    M. L. Stadius, C. Maynard, J. K. Fritz et al. Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: the Western Washington randomised intracoronary streptokinase trial, Circulation, 72:292–301 (1985).PubMedCrossRefGoogle Scholar
  10. 10.
    E. J. Topoi, R. M. Califf, B. S. George et al, Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials, J. Am. Coll. Cardiol., 12:24A–31A (1988).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Harvey D. White
    • 1
  1. 1.Cardiovascular ResearchGreen Lane HospitalAucklandNew Zealand

Personalised recommendations